Copyright
©The Author(s) 2025.
World J Gastroenterol. Jul 7, 2025; 31(25): 105677
Published online Jul 7, 2025. doi: 10.3748/wjg.v31.i25.105677
Published online Jul 7, 2025. doi: 10.3748/wjg.v31.i25.105677
Figure 3 Before and after 3 months and 6 months of sirolimus administration.
A: Average bleeding episodes; B: Average hemoglobin concentration; C: The clinical effectiveness score. bP < 0.01. cP < 0.001. P were compared with pre-sirolimus. Hb: Hemoglobin.
- Citation: Sun Q, Wu JC, Chen X, Li DH, Li BR, Xiao NJ, Wang XY, Tu XZ, Ning SB, Sun T. Efficacy and safety of sirolimus in the treatment of gastrointestinal angiodysplasias. World J Gastroenterol 2025; 31(25): 105677
- URL: https://www.wjgnet.com/1007-9327/full/v31/i25/105677.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i25.105677